European Medicines Agency Recommends Approval for Dozen New Drugs

The European Medicines Agency's CHMP has issued positive recommendations for 12 new medications, signaling potential availability in the European market. Among these is Icotyde, an oral treatment for plaque psoriasis, and an expanded indication for Piqray in breast cancer. The committee also delivered negative opinions for three other medicines.